Keishibukuryogan is not carcinogenic in Sprague-Dawley rats
Keishibukuryogan is a traditional Japanese medicine widely administered to patients with menopausal symptoms. Because humans use it on a long-term basis, we believed that a carcinogenicity study was warranted. We orally administered keishibukuryogan (TJ-25) extract powder to 6-week-old Sprague-Dawl...
| Main Authors: | , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Japanese Society of Toxicologic Pathology
2016
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4866007/ |